Published in PLoS Genet on August 15, 2008
Telomerase is required for zebrafish lifespan. PLoS Genet (2013) 1.59
The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. Curr Biol (2008) 1.47
Biomarkers of aging in Drosophila. Aging Cell (2010) 1.38
Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-γ and p53 signaling. Nat Chem Biol (2012) 1.15
Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain (2012) 1.14
Behaviour of telomere and telomerase during aging and regeneration in zebrafish. PLoS One (2011) 1.12
A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesis. PLoS One (2008) 1.08
Parallel evolution of senescence in annual fishes in response to extrinsic mortality. BMC Evol Biol (2013) 1.07
Stressing zebrafish for behavioral genetics. Rev Neurosci (2011) 1.02
Premature aging in telomerase-deficient zebrafish. Dis Model Mech (2013) 1.01
Colorimetric detection of senescence-associated β galactosidase. Methods Mol Biol (2013) 0.99
Zebrafish as a genetic model in biological and behavioral gerontology: where development meets aging in vertebrates--a mini-review. Gerontology (2009) 0.96
Genetic evidence of an evolutionarily conserved role for Nrf2 in the protection against oxidative stress. Mol Cell Biol (2012) 0.94
Life-long preservation of the regenerative capacity in the fin and heart in zebrafish. Biol Open (2012) 0.94
Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing. PLoS One (2012) 0.92
Quantifiable biomarkers of normal aging in the Japanese medaka fish (Oryzias latipes). PLoS One (2010) 0.91
Expression of telomerase and telomere length are unaffected by either age or limb regeneration in Danio rerio. PLoS One (2009) 0.91
The short-lived African turquoise killifish: an emerging experimental model for ageing. Dis Model Mech (2016) 0.85
Analysis of cell proliferation, senescence, and cell death in zebrafish embryos. Methods Cell Biol (2011) 0.85
Senescence and life span. Pflugers Arch (2009) 0.84
Embryonic senescence and laminopathies in a progeroid zebrafish model. PLoS One (2011) 0.84
Gene expression changes in aging zebrafish (Danio rerio) brains are sexually dimorphic. BMC Neurosci (2014) 0.84
Retroviral-mediated Insertional Mutagenesis in Zebrafish. Methods Cell Biol (2011) 0.83
Aberrant autolysosomal regulation is linked to the induction of embryonic senescence: differential roles of Beclin 1 and p53 in vertebrate Spns1 deficiency. PLoS Genet (2014) 0.81
NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish. J Biol Chem (2014) 0.80
Cug2 is essential for normal mitotic control and CNS development in zebrafish. BMC Dev Biol (2011) 0.79
Protective role of cell division cycle 48 (CDC48) protein against neurodegeneration via ubiquitin-proteasome system dysfunction during zebrafish development. J Biol Chem (2012) 0.79
Molecular and chemical genetic approaches to developmental origins of aging and disease in zebrafish. Biochim Biophys Acta (2013) 0.78
Spatio-Temporal Differences in Dystrophin Dynamics at mRNA and Protein Levels Revealed by a Novel FlipTrap Line. PLoS One (2015) 0.78
The Polycomb Group Protein Pcgf1 Is Dispensable in Zebrafish but Involved in Early Growth and Aging. PLoS One (2016) 0.77
The viral TRAF protein (ORF111L) from infectious spleen and kidney necrosis virus interacts with TRADD and induces caspase 8-mediated apoptosis. PLoS One (2012) 0.77
Oxidative stress and regulation of Pink1 in zebrafish (Danio rerio). PLoS One (2013) 0.76
Granulin knock out zebrafish lack frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis pathology. PLoS One (2015) 0.76
Autolysosome biogenesis and developmental senescence are regulated by both Spns1 and v-ATPase. Autophagy (2016) 0.75
Short Telomeres in Key Tissues Initiate Local and Systemic Aging in Zebrafish. PLoS Genet (2016) 0.75
SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage. Nucleic Acids Res (2016) 0.75
Using zebrafish models to explore genetic and epigenetic impacts on evolutionary developmental origins of aging. Transl Res (2013) 0.75
Todralazine protects zebrafish from lethal effects of ionizing radiation: role of hematopoietic cell expansion. Zebrafish (2014) 0.75
Telomeres in aging and disease: lessons from zebrafish. Dis Model Mech (2016) 0.75
Stages of embryonic development of the zebrafish. Dev Dyn (1995) 42.72
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Oxidants, oxidative stress and the biology of ageing. Nature (2000) 23.21
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19
Mammalian telomeres end in a large duplex loop. Cell (1999) 12.12
Oxidative stress, caloric restriction, and aging. Science (1996) 11.07
TRF2 protects human telomeres from end-to-end fusions. Cell (1998) 10.13
Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A (2004) 5.54
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol (2005) 5.49
Protection of mammalian telomeres. Oncogene (2002) 5.38
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res (2000) 4.82
Oxidative stress in neurodegeneration: cause or consequence? Nat Med (2004) 4.72
Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol (1994) 4.05
A large-scale insertional mutagenesis screen in zebrafish. Genes Dev (1999) 3.57
RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res (2005) 3.52
Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell (2006) 3.24
The art and design of genetic screens: zebrafish. Nat Rev Genet (2001) 3.24
Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med (2002) 3.09
Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci (2000) 3.03
p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev (2005) 3.02
Unrestricted synaptic growth in spinster-a late endosomal protein implicated in TGF-beta-mediated synaptic growth regulation. Neuron (2002) 2.87
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev (2003) 2.78
The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem (2002) 2.67
Age-related changes in liver structure and function: Implications for disease ? Exp Gerontol (2005) 2.49
Neurodegenerative diseases and oxidative stress. Biomed Pharmacother (2004) 2.44
From Zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet (2002) 2.07
Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet (2006) 2.01
The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol (2004) 1.98
Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development (2003) 1.95
Lipofuscin: formation, distribution, and metabolic consequences. Ann N Y Acad Sci (2007) 1.93
Lipofuscin. Int J Biochem Cell Biol (2004) 1.75
Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A (1999) 1.57
The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc Natl Acad Sci U S A (2007) 1.45
Mutations in the novel membrane protein spinster interfere with programmed cell death and cause neural degeneration in Drosophila melanogaster. Mol Cell Biol (2001) 1.35
Annual fishes of the genus Nothobranchius as a model system for aging research. Aging Cell (2005) 1.31
Comparison of mitochondrial pro-oxidant generation and anti-oxidant defenses between rat and pigeon: possible basis of variation in longevity and metabolic potential. Mech Ageing Dev (1993) 1.31
Life spans and senescent phenotypes in two strains of Zebrafish (Danio rerio). Exp Gerontol (2002) 1.29
Temperature affects longevity and age-related locomotor and cognitive decay in the short-lived fish Nothobranchius furzeri. Aging Cell (2006) 1.29
Lipofuscin: mechanisms of formation and increase with age. APMIS (1998) 1.29
The zebrafish as a vertebrate model of functional aging and very gradual senescence. Exp Gerontol (2003) 1.28
Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays (1997) 1.27
The biochemistry of aging muscle. Exp Gerontol (2002) 1.24
A dominant form of inherited retinal degeneration caused by a non-photoreceptor cell-specific mutation. Proc Natl Acad Sci U S A (1997) 1.24
Pigments in aging: an overview. Ann N Y Acad Sci (2002) 1.21
Lipofuscin and aging: a matter of toxic waste. Sci Aging Knowledge Environ (2005) 1.20
Cognitive aging in zebrafish. PLoS One (2006) 1.12
Functional aging and gradual senescence in zebrafish. Ann N Y Acad Sci (2004) 1.11
Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors. Oncogene (2001) 1.09
The use of mature zebrafish (Danio rerio) as a model for human aging and disease. Comp Biochem Physiol C Toxicol Pharmacol (2004) 1.03
ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab Invest (2005) 1.03
Retroviral-mediated insertional mutagenesis in zebrafish. Methods Cell Biol (2004) 1.02
Differential effects of genotoxic stress on both concurrent body growth and gradual senescence in the adult zebrafish. Aging Cell (2007) 1.02
Oxidative stress in ataxia telangiectasia. Redox Rep (2003) 1.00
Aging of the circadian system in zebrafish and the effects of melatonin on sleep and cognitive performance. Brain Res Bull (2007) 0.99
Disruption of the olfactoretinal centrifugal pathway may relate to the visual system defect in night blindness b mutant zebrafish. J Neurosci (2000) 0.99
Telomere protection mechanisms change during neurogenesis and neuronal maturation: newly generated neurons are hypersensitive to telomere and DNA damage. J Neurosci (2007) 0.98
TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons. J Neurochem (2006) 0.97
Zebrafish yolk-specific not really started (nrs) gene is a vertebrate homolog of the Drosophila spinster gene and is essential for embryogenesis. Dev Dyn (2002) 0.93
Comparative aspects of zebrafish (Danio rerio) as a model for aging research. Exp Gerontol (2003) 0.93
ENU-induced late-onset night blindness associated with rod photoreceptor cell degeneration in zebrafish. Mech Ageing Dev (2003) 0.91
Behavioral screening for nightblindness mutants in zebrafish reveals three new loci that cause dominant photoreceptor cell degeneration. Mech Ageing Dev (2005) 0.82
Fluorescent and cross-linked proteins formed by free radical and aldehyde species generated during lipid oxidation. Adv Exp Med Biol (1989) 0.81
Lipofuscin in bovine muscle and brain: a model for studying age pigment. Gerontology (1995) 0.81
Cloning and expression of a cDNA coding for catalase from zebrafish (Danio rerio). J Agric Food Chem (2000) 0.78
Molecular cloning and sequence analysis of the Danio rerio catalase gene. Comp Biochem Physiol B Biochem Mol Biol (2000) 0.77
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature (2010) 14.62
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood (2004) 11.07
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov (2009) 10.59
Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med (2011) 9.90
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell (2005) 7.99
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell (2007) 7.60
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A (2006) 6.80
A histone H3 lysine 27 demethylase regulates animal posterior development. Nature (2007) 6.57
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med (2003) 6.07
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature (2008) 6.04
The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell (2007) 6.04
A genetic screen for candidate tumor suppressors identifies REST. Cell (2005) 5.61
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science (2005) 5.56
Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet (2002) 5.43
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci U S A (2005) 4.15
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol (2003) 4.07
A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development (2004) 3.97
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. Blood (2004) 3.84
Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell (2011) 3.81
The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells. Proc Natl Acad Sci U S A (2005) 3.72
Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med (2005) 3.35
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell (2003) 3.33
A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell (2003) 3.29
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell (2008) 3.15
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood (2009) 3.02
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol (2012) 2.92
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. Cancer Res (2002) 2.83
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease. Cancer Cell (2003) 2.70
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood (2004) 2.60
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discov (2013) 2.52
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell (2012) 2.51
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol (2006) 2.40
Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res (2012) 2.39
Human tumor mutants in the p110alpha subunit of PI3K. Cell Cycle (2006) 2.39
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol (2003) 2.36
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res (2004) 2.32
The p110alpha isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc Natl Acad Sci U S A (2006) 2.23
DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature (2011) 2.23
Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature (2010) 2.20
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci U S A (2005) 2.19
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest (2005) 2.15
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol (2005) 2.14
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis. Proc Natl Acad Sci U S A (2011) 2.14
A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development (2005) 2.12
Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat Chem Biol (2006) 2.08
IAP inhibitors enhance co-stimulation to promote tumor immunity. J Exp Med (2010) 2.07
Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays. BMC Genomics (2004) 2.05
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04
The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest (2007) 1.98
DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev (2006) 1.96
A zebrafish sox9 gene required for cartilage morphogenesis. Development (2002) 1.94
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). Cancer Cell (2002) 1.91
Retraction in amoeboid cell motility powered by cytoskeletal dynamics. Science (2003) 1.89
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood (2005) 1.89
Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell (2002) 1.86
Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood (2011) 1.84
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood (2010) 1.82
Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs. Proc Natl Acad Sci U S A (2004) 1.82
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol (2005) 1.78
Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One (2007) 1.72
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol (2007) 1.63
Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A (2008) 1.63
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol (2007) 1.62
Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment. Neurology (2013) 1.62
Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood (2009) 1.61
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc Natl Acad Sci U S A (2008) 1.59
NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood (2005) 1.59
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol (2009) 1.57
Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell (2012) 1.54
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01. Blood (2007) 1.53
Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition. Cancer Res (2013) 1.52
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia. Clin Cancer Res (2008) 1.52
NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. PLoS One (2013) 1.50
Phosphoinositide 3-kinase is required for process outgrowth and cell polarization of gastrulating mesendodermal cells. Curr Biol (2003) 1.50
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy. Clin Cancer Res (2005) 1.48
A vertebrate gene, ticrr, is an essential checkpoint and replication regulator. Genes Dev (2010) 1.47
Should individual PI3 kinase isoforms be targeted in cancer? Curr Opin Cell Biol (2009) 1.47
Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am J Hum Genet (2013) 1.46
Targeting the follicular lymphoma microenvironment through blockade of TNFalpha with etanercept. Leuk Lymphoma (2008) 1.46
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia. Clin Cancer Res (2011) 1.46
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin Cancer Res (2007) 1.44
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood (2005) 1.43
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol (2008) 1.42
Employment and insurance in survivors of Hodgkin lymphoma and their siblings: a questionnaire study. Leuk Lymphoma (2012) 1.42
Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc Natl Acad Sci U S A (2004) 1.42
Zebrafish foxi one modulates cellular responses to Fgf signaling required for the integrity of ear and jaw patterning. Development (2003) 1.41
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood (2010) 1.40